D.E. Shaw & Co
BNGO icon

D.E. Shaw & Co’s Bionano Genomics BNGO Stock Holding History

D.E. Shaw & Co’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,863
Closed -$325K – 4357
2023
Q4 		$325K Buy
+2,863
New +$299K ﹤0.01% 3712
2022
Q4 		– Sell
-465
Closed -$511K – 4872
2022
Q3 		$511K Buy
465
+446
+2,347% +$589K ﹤0.01% 4030
2022
Q2 		$16K Sell
19
-681
-97% -$701K ﹤0.01% 5060
2022
Q1 		$1.08M Buy
700
+616
+733% +$832K ﹤0.01% 3851
2021
Q4 		$151K Buy
+84
New +$225K ﹤0.01% 4963
2021
Q3 		– Sell
-18
Closed -$81K – 4964
2021
Q2 		$81K Buy
+18
New +$71.1K ﹤0.01% 4580

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co's BNGO Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Bionano Genomics (BNGO) in Q1 2024, closing a stake of 2,863 shares — an estimated $325K sold.

D.E. Shaw & Co first reported a position in BNGO in Q2 2021 and held it in 6 quarters. The position peaked at $1.08M in Q1 2022. 55 funds tracked by Wall St. Rank hold BNGO as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Bionano Genomics position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 2,863 Bionano Genomics shares in Q1 2024, an estimated $325K.
  • D.E. Shaw & Co first reported a position in Bionano Genomics in Q2 2021 and held it in 6 quarters.
  • D.E. Shaw & Co's Bionano Genomics position peaked at $1.08M in Q1 2022.
  • 55 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.